Related Experiment Video
Updated: Jun 17, 2026
06:06
Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
Published on: March 9, 2019
Protein C inhibitor--a novel antimicrobial agent
Erik Malmström1, Matthias Mörgelin, Martin Malmsten
1Department of Clinical Sciences, Section for Clinical and Experimental Infection Medicine, Lund University, Lund, Sweden.
Plos Pathogens
|December 19, 2009
Summary
Protein C inhibitor (PCI) demonstrates broad antimicrobial activity by disrupting bacterial membranes. A specific peptide mimics this effect, highlighting PCI's novel role in innate immunity against pathogens.
Area of Science:
- Biochemistry
- Immunology
- Microbiology
Background:
- Protein C inhibitor (PCI) is a serpin proteinase inhibitor.
- PCI is known to bind heparin.
Purpose of the Study:
- To investigate the antimicrobial properties of PCI.
- To elucidate the mechanism of PCI's antimicrobial activity.
- To explore the role of PCI in innate immunity.
Main Methods:
- Treatment of bacterial pathogens (Escherichia coli, Streptococcus pyogenes) with PCI.
- Negative staining electron microscopy to visualize membrane disruption.
- Analysis of PCI's heparin-binding site and associated peptides.
- Investigation of PCI assembly on activated platelets.
Main Results:
- PCI exhibits broad-spectrum antimicrobial activity against bacterial pathogens.
- PCI interacts with and permeabilizes bacterial lipid membranes, causing cell death.
- A peptide mimicking PCI's heparin-binding site retains antimicrobial activity without harming eukaryotic cells.
- Activated platelets can display PCI on their surface.
- Elevated PCI levels are observed in tissue biopsies from patients with necrotizing fasciitis.
Conclusions:
- PCI possesses a novel antimicrobial function mediated by membrane permeabilization.
- PCI's antimicrobial activity is linked to its heparin-binding site.
- Platelet-associated PCI may contribute to the host's defense against bacterial infections.
- PCI plays a significant role in innate immunity.
Related Concept Videos
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...